- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Spotlight On Tobacco
U.S. Pharmaceuticals & Biotech Spotlight On Tobacco
UPDATED May 02, 2024
Get exposure to an age-old industry - tobacco.
1,859 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$755.91 | 4.3% | 76.4% | US$699.4b | US$848.35 | PE110.9x | E27.0% | 0.7% | ||
NONO.F | kr.124.22 | 0.6% | 55.3% | kr.3.9t | kr.128.93 | PE43.4x | E14.6% | 1.1% | ||
NVO | kr.124.02 | -1.4% | 54.6% | kr.3.9t | kr.128.72 | PE43.4x | E14.6% | 1.1% | ||
JNJ | US$149.92 | 2.1% | -7.5% | US$363.8b | US$173.26 | PE21.1x | E7.0% | 3.3% | ||
MRK | US$128.26 | -1.9% | 9.3% | US$326.3b | US$141.64 | PE140.9x | E24.9% | 2.4% | ||
ABBV | US$160.81 | -3.9% | 9.1% | US$286.3b | US$182.31 | PE47.9x | E23.3% | 3.9% | ||
AZN | UK£75.81 | 1.0% | 1.9% | UK£188.4b | UK£82.11 | PE37.3x | E16.5% | 2.0% | ||
AZNC.F | UK£153.48 | 5.1% | 2.0% | UK£188.4b | UK£166.23 | PE37.3x | E16.5% | 2.0% | ||
TMO | US$571.25 | -0.08% | 4.7% | US$219.5b | US$625.47 | PE36.1x | E10.6% | 0.3% | ||
NVS | CHF97.34 | -1.7% | -7.0% | CHF181.3b | CHF109.18 | PE21.9x | E10.1% | 3.7% | ||
NVSE.F | CHF97.00 | 1.0% | -3.0% | CHF181.3b | CHF108.57 | PE21.9x | E10.1% | 3.7% | ||
RHHB.Y | CHF29.26 | -2.5% | -26.2% | CHF172.8b | CHF38.18 | PE14.8x | E8.6% | 4.5% | ||
RHHB.F | CHF259.00 | -5.3% | -23.8% | CHF172.8b | CHF337.98 | PE14.8x | E8.6% | 4.5% | ||
RHHV.F | CHF235.30 | -1.0% | -26.3% | CHF172.8b | CHF307.05 | PE14.8x | E8.6% | 4.5% | ||
DHR | US$246.84 | 0.4% | 1.9% | US$182.9b | US$272.68 | PE44.9x | E13.5% | 0.4% | ||
DHR.WI | US$220.75 | 0.3% | n/a | US$157.8b | US$286.99 | PE25.3x | E6.7% | 0.5% | ||
PFE | US$27.70 | 9.7% | -27.5% | US$153.9b | US$31.89 | PE73.5x | E22.0% | 6.1% | ||
AMGN | US$278.39 | 3.3% | 20.1% | US$148.8b | US$298.30 | PE22.2x | E9.1% | 3.2% | ||
SNY | €49.46 | 0.2% | -9.6% | €114.8b | €58.16 | PE25.3x | E16.6% | 4.1% | ||
SNYN.F | €100.00 | 4.7% | -7.0% | €114.8b | €116.09 | PE25.6x | E16.6% | 4.0% | ||
VRTX | US$400.16 | 0.6% | 15.5% | US$103.9b | US$460.23 | PE28.6x | E11.4% | n/a | ||
REGN | US$937.61 | 5.3% | 24.4% | US$97.5b | US$1,037.45 | PE26.2x | E11.8% | n/a | ||
BMY | US$43.70 | -2.2% | -34.6% | US$89.6b | US$53.32 | PS1.9x | E43.1% | 5.5% | ||
GSK | UK£43.35 | 6.0% | 18.1% | UK£70.5b | UK£50.65 | PE15.7x | E11.9% | 3.4% |